News › GlobeNewswire Inc.

INSP DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important January 5 Deadline in Securities Class Action - INSP

GlobeNewswire Inc. • Dec 31, 2025 1:44pm (New York) •By Rosen Law Firm

INSP DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important January 5 Deadline in Securities Class Action - INSP

Rosen Law Firm is reminding investors in Inspire Medical Systems (INSP) who purchased stock between August 6, 2024 and August 4, 2025 of the January 5, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Inspire Medical misrepresented and failed to disclose key facts about its Inspire V sleep apnea device, including actual market demand and launch readiness, causing investor losses.

← Back to news Read Original Article

Insights

SCHD positive

Offers strong dividend yield of 3.8%, holds blue-chip stocks, and potentially positioned for a market shift from growth to value stocks

INSP negative

The company is the subject of a securities class action lawsuit alleging material misrepresentations and non-disclosures regarding the Inspire V device's market demand and launch readiness, resulting in investor damages.

Keywords

#securities class action #Inspire Medical Systems #Inspire V device #misrepresentation #investor losses #lead plaintiff deadline #sleep apnea device

Tickers

INSP

← Prev: Tower Semiconductor Draws New $109 Million Institutional Stake Amid a 127% Stock Run

Next: LRN 13-DAY DEADLINE ALERT: Stride (LRN) Investors Encouraged to Contact Hagens Berman, Securities Class Action Pending Over Alleged Undisclosed Operational Failures →